NCT04018274 - Effect of PF-06651600 on the Pharmacokinetics of Oral Contraceptive Steroids | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 9, 2019

Primary Completion Date

October 16, 2019

Study Completion Date

October 16, 2019

Conditions

Healthy

Interventions

DRUG

PF-06651600

50 mg by mouth (PO) once daily (QD)

DRUG

Ethinyl estradiol (EE) and levonorgestrel(LN)

Oral tablet containing 30 ug EE and 150 ug of LN

Trial Locations (2)

Quotient Sciences, Miami, Miami

Quotient Sciences Screening Office, Coral Gables